EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Wnt signaling pathway-targeted antitumor therapeutics in clinical translation: Advances and challenges

Chen Xue, Danhua Zhu, Lanjuan Li

Current Pharmaceutical Analysis · 2026-06 · 22 (5) · 375-378

DOI: 10.1016/j.cpan.2026.03.009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Pharmaceutical Analysis, 2026-06. Verfasst von Chen Xue und 2 weiteren Autor:innen. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Development Fund, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Fundamental Research Funds for the Central Universities.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • Science and Technology Development Fund
  • State Key Laboratory for Diagnosis and Treatment of Infectious Diseases
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Xue, C., Zhu, D., & Li, L. (2026). Wnt signaling pathway-targeted antitumor therapeutics in clinical translation: Advances and challenges. Current Pharmaceutical Analysis, 22(5), 375-378. https://doi.org/10.1016/j.cpan.2026.03.009

Vancouver

Xue C, Zhu D, Li L. Wnt signaling pathway-targeted antitumor therapeutics in clinical translation: Advances and challenges. Current Pharmaceutical Analysis. 2026;22(5):375-378. doi:10.1016/j.cpan.2026.03.009

BibTeX
@article{Xue2026,
  author = {Xue, Chen and Zhu, Danhua and Li, Lanjuan},
  title = {Wnt signaling pathway-targeted antitumor therapeutics in clinical translation: Advances and challenges},
  journal = {Current Pharmaceutical Analysis},
  year = {2026},
  volume = {22},
  number = {5},
  pages = {375--378},
  doi = {10.1016/j.cpan.2026.03.009}
}
Kostenlos starten →